Schamroth Pravda M, Cohen Hagai K, Topaz G, et al. - Researchers investigated the utility of CHA₂DS₂-VASc score for risk stratification of patients with end-stage renal disease (ESRD) receiving chronic hemodialysis. At the start of hemodialysis, CHA₂DS₂-VASc score was computed for each patient. Based on the CHA₂DS₂-VASc score, 3 groups were defined: 0–3 (low), 4–5 (intermediate), and ≥ 6 (high). The composite of all-cause death, myocardial infarction, and stroke during the first year of hemodialysis was the primary endpoint. Findings revealed extremely high death as well as cardiovascular risk within the first year of hemodialysis in ESRD patients. A strong correlation of CHA₂DS₂-VASc score with adverse outcomes was identified, and the CHA₂DS₂-VASc score may be applied for risk stratification of these patients.